凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
交大昂立(600530)公告正文

交大昂立:2012年年度报告摘要

公告日期 2013-04-10
股票简称:交大昂立 股票代码:600530
                                   2012 年年度报告摘要
                           2012 年年度报告摘要一、 重要提示1.1 本年度报告摘要摘自年度报告全文,投资者欲了解详细内容,应当仔细阅读同时刊载于上海证券交易所网站等中国证监会指定网站上的年度报告全文。
    1.2   公司简介
         股票简称             交大昂立             股票代码                 600530
      股票上市交易所                                上海证券交易所
      联系人和联系方式           董事会秘书                        证券事务代表
           姓名           娄健颖                         孙英
           电话           021-54277900                  021-54277820
           传真           021-54277827                  021-54277827
         电子信箱         stock@mail.onlly.com.cn        stock@mail.onlly.com.cn二、 主要财务数据和股东变化2.1 主要财务数据
                                                                    单位:元 币种:人民币
                                                                   本年
                                                                 (末)比
                           2012 年(末)          2011 年(末)        上年       2010 年(末)
                                                                 (末)增
                                                                 减(%)
    总资产                   1,854,544,198.86   1,694,346,312.63      9.4548    1,315,438,129.02归属于上市公司股东的
                         1,470,521,926.62   1,361,610,562.15      7.9987    1,058,868,270.54净资产经营活动产生的现金流
                           20,014,770.55         -2,689,556.33    844.17      12,816,572.11量净额
    营业收入                  375,271,863.91        350,940,124.11       6.93    338,984,391.09归属于上市公司股东的
                           83,152,251.91         55,602,502.72   49.5477      58,004,741.66净利润归属于上市公司股东的
    扣除非经常性损益的净          451,525.17         27,330,619.01   -98.3479     19,713,159.64利润
                                                                    增加加权平均净资产收益率
                                     5.87                 4.60    1.27 个               6.63(%)
                                                                  百分点
    基本每股收益(元/股)             0.267                 0.178   49.5477              0.186
    稀释每股收益(元/股)             0.267                 0.178   49.5477              0.186
                                        2012 年年度报告摘要
    2.2   前 10 名股东持股情况表
                                                                                      单位:股
                                                        年度报告披露日前第 5
      截止报告期末股东总数(户)               25,162   个交易日末股东总数              24,855
                                                              (户)
                                    前十名股东持股情况
                                                                      持有有限
                     股东      持股比                    报告期内                质押或冻结
      股东名称                             持股总数                   售条件股
                     性质      例(%)                       增减                  的股份数量
                                                                        份数量
                    境 内
    上海新南洋股份     非 国
                               18.795     58,639,782      2,998,782          0   无
    有限公司           有 法
                    人
                  境 内大众交通(集团) 非 国
                               17.261     53,855,849             0           0   无
    股份有限公司     有 法
                  人
    上海新路达商业     国 有
                                6.153     19,197,491             0           0   无
    (集团)有限公司   法人
                    境 内
    上海茸北工贸实     非 国                                                          质押
                                5.038     15,717,765             0           0
    业总公司           有 法                                                          9,000,000
                    人
                    境 内
    上海蓝鑫投资有     非 国
                                4.238     13,223,600             0           0   无
    限公司             有 法
                    人
    上海国际株式会     境 外
                                2.818       8,792,600            0           0   无
    社                 法人
    上海市教育发展     国 有
                                1.330       4,149,600            0           0   无
    有限公司           法人
                    境 内
    徐开东             自 然       1.102       3,438,005     3,438,005          0   未知
                    人中国银河证券股份有限公司客户
                    其他        0.991       3,090,836     3,090,836          0   未知信用交易担保证券账户
    上海交通大学       国家        0.289       2,766,400            0           0   无
    上述股东关联关系或一致行动        上海新南洋股份有限公司与上海交通大学存在关联关系,
           的说明                  其他股东间是否存在关联关系不祥。
                                      2012 年年度报告摘要
    2.3   以方框图描述公司与实际控制人之间的产权及控制关系
                    教育部
        100%
                   上海交通大学
        38.446%
            上海新南洋股份有限公司
      18.795%
           上海交大昂立股份有限公司三、 管理层讨论与分析3.1 董事会关于公司报告期内经营情况的讨论与分析2012 年度,公司实现营业收入 37,527.19 万元,营业成本 12,959.22 万元,利润总额 10,134.28万元,归属于母公司所有者的净利润为 8,315.23 万元。(一) 主营业务分析1、 利润表及现金流量表相关科目变动分析表
                                                                     单位:元 币种:人民币
    科目                                     本期数              上年同期数        变动比例(%)
    营业收入                                   375,271,863.91     350,940,124.11            6.93
    营业成本                                   129,592,237.53     124,651,496.50            3.96
    销售费用                                   169,390,836.45     152,974,115.42          10.73
    管理费用                                     65,423,879.97     64,878,269.82            0.84
    财务费用                                      4,923,058.10      4,910,229.99            0.26
    经营活动产生的现金流量净额                   20,014,770.55     -2,689,556.33         844.17
    投资活动产生的现金流量净额                   13,211,183.53    -79,989,216.34         116.52
    筹资活动产生的现金流量净额                  -22,641,661.82     42,677,260.44         -153.05
    研发支出                                     12,092,734.04     11,331,893.06            6.712、 收入(1)驱动业务收入变化的因素分析本期业务收入与上年度相比,无明显变化。(2) 以实物销售为主的公司产品收入影响因素分析公司以实物销售为主的产品收入主要为昂立功能保健品、天然元营养补充剂以及植物提取
                                       2012 年年度报告摘要物。本年产品收入与去年同比有一定幅度增长。(3) 订单分析公司本年度产品销售渠道主要以零售业务为主,订单收入占比较小。(4) 新产品及新服务的影响分析公司本年度产品或服务未发生重大变化或调整。(5) 主要销售客户的情况
                                                    占公司全部营业收入的比
    客户名称              营业收入总额
                                                    例(%)
    1                     81,716,200.39                 21.78
    2                     23,401,878.56                 6.24
    3                     22,148,693.84                 5.90
    4                     12,099,004.03                 3.22
    5                     8,661,770.03                  2.31
    合 计                 148,027,546.85                39.453、 成本(1) 成本分析表
                                                                                         单位:元分行业情况
                                                                                           本期金
                                                   本期占                      上年同
                                                                                           额较上
                   成本构成                        总成本                      期占总
    分行业                       本期金额                   上年同期金额                  年同期
                     项目                            比例                      成本比
                                                                                           变动比
                                                     (%)                       例(%)
                                                                                           例(%)
                   原材料、
                   人 工 工
    (1)工   业                   111,781,418.95       86.89   111,794,915.93     90.25        -0.01
                   资、折旧、
                   能源等
                   原材料、
    (2)商   业      人工工资     207,372,993.34      161.19   192,749,223.57    155.60         7.59
                   等
                   人 工 工
    (3)房地产业     资、折旧        1,036,741.64       0.81       943,178.10       0.76        9.92
                   等
    (4)外   贸      原材料等            15,213.66      0.01       754,328.33       0.61      -97.98
    (5)租   赁      折旧等          1,027,289.54       0.80      1,068,402.06      0.86       -3.85公 司内 各 业务
                                -192,584,271.94    -149.70   -183,439,033.56   -148.09分布相互抵消
    合   计                     128,649,385.19      100.00   123,871,014.43    100.00         3.86
                                     2012 年年度报告摘要分产品情况
                                                                                            本期金
                                                 本期占                            上年同
                                                                                            额较上
               成本构成                          总成本                            期占总
    分产品                   本期金额                        上年同期金额                   年同期
                 项目                            比例                              成本比
                                                                                            变动比
                                                   (%)                             例(%)
                                                                                            例(%)
             原材料、人
    1、保健品    工工资、折      90,868,207.54        70.63            87,570,980.66    70.70      3.77
             旧、能源等
             原材料、人
    2、其他      工工资、折      37,781,177.65        29.37            36,300,033.77    29.30      4.08
             旧、能源等
    合      计                  128,649,385.19       100.00           123,871,014.43   100.00      3.86(2) 主要供应商情况
                                                          占公司全部营业成本
    客户名称             营业成本总额
                                                          的比例(%)
    1                    7,435,897.44                         5.73
    2                    7,283,079.84                         5.62
    3                    2,452,393.16                         1.89
    4                    2,141,626.84                         1.65
    5                    2,074,511.45                         1.60
    合 计                21,387,508.73                        16.494、 费用
                                                              单位:元
    项目                      本期金额          上期金额            增减率
    销售费用                  169,390,836.45    152,974,115.42      10.73%
    管理费用                  65,423,879.97     64,878,269.82       0.84%
    财务费用                  4,923,058.10      4,910,229.99        0.26%
    所得税费用                17,873,693.33     5,950,337.56        200.38%本报告期内所得税费用同比增长 200.38%,主要原因是本期利润增加,相应增加所得税费用。5、 研发支出(1) 研发支出情况表
                                                                       单位:元
    本期费用化研发支出                                                       12,092,734.04
    本期资本化研发支出                                                                 0.00
    研发支出合计                                                             12,092,734.04
    研发支出总额占净资产比例(%)                                                      0.79
    研发支出总额占营业收入比例(%)                                                    3.22
                                     2012 年年度报告摘要6、 现金流
                                                                                         单位:元
    项目                               本期金额                       上期金额                         增减率
    经营活动产生的现金流量净额                 20,014,770.55                -2,689,556.33              844.17%
    投资活动产生的现金流量净额                 13,211,183.53               -79,989,216.34              116.52%
    筹资活动产生的现金流量净额                -22,641,661.82                42,677,260.44              -153.05%1、经营活动产生的现金流量净额增加的主要原因是本期收到昂泰公司预分红款及本年末预付 款较去年同期减少。2、投资活动产生的现金流量净额增加的主要原因是去年同期出资 16,989.74 万元增持国泰君安证券股份有限股权;本期出资 7500 万元发起成立上海徐汇昂立小额贷款股份有限公司。3、筹资活动产生的现金流量净额减少的主要原因是本期获得银行短期借款较去年同期减少4000 万元;本期归还银行短期借款较去年同期增加 1000 万元。7、其它(1) 公司利润构成或利润来源发生重大变动的详细说明
                                                                        单位:元
    项目                 本期金额                      上期金额               增减率
    资产减值损失         7,496,304.44                  1,032,827.33           625.80%
    投资收益             105,848,330.56                58,365,432.37          81.35%1、资产减值损失增加主要原因是本期计提的坏账准备金额增加。2、投资收益增加主要原因是减持兴业证券股票,收益同比大幅增加。(二) 行业、产品或地区经营情况分析1、 主营业务分行业、分产品情况
                                                                               单位:元 币种:人民币
                                         主营业务分行业情况
                                                                      营业      营业
                                                                      收入      成本
                                                          毛利率                          毛利率比上年增减
    分行业         营业收入            营业成本                      比上      比上
                                                          (%)                                (%)
                                                                      年增      年增
                                                                      减(%)     减(%)
    (1)工      业   206,105,844.21      111,781,418.95        45.77     12.77      -0.01     增加 6.93 个百分点
    (2)商      业   345,584,314.32      207,372,993.34        39.99      3.17       7.59     减少 2.46 个百分点
    (3)房地产业        4,752,941.00       1,036,741.64        78.19     19.82       9.92     增加 1.96 个百分点
    (4)外      贸        15,384.62           15,213.66         1.11     -97.99    -97.98     减少 0.32 个百分点
    (5)租      赁      3,619,674.30       1,027,289.54        71.62      5.83      -3.85     增加 2.86 个百分点公司内各业务分
                  -189,154,365.52    -192,584,271.94布相互抵消
    合    计      370,923,792.93      128,649,385.19        65.32      9.91       3.86     增加 2.02 个百分点
                                         主营业务分产品情况
                                        2012 年年度报告摘要
                                                                                营业
                                                                    营业收
                                                                                成本
                                                           毛利率   入比上                 毛利率比上年增减
    分产品              营业收入         营业成本                              比上
                                                           (%)   年增减                       (%)
                                                                                年增
                                                                      (%)
                                                                                减(%)
    1、保健品              311,890,113.04    90,868,207.54      70.87        9.70    3.77       增加 1.67 个百分点
    2、其他                 59,033,679.89    37,781,177.65      36.00     11.04      4.08       增加 4.28 个百分点
    合     计          370,923,792.93   128,649,385.19      65.32        9.91    3.86       增加 2.02 个百分点2、 主营业务分地区情况
                                                                           单位:元 币种:人民币
                地区                        营业收入                营业收入比上年增减(%)
    上海地区                                  460,768,392.97                         5.42
    其他地区                                  99,309,765.48                          11.85
    公司内各业务分布相互抵消                 -189,154,365.52
           合     计                      370,923,792.93                         9.91(三) 资产、负债情况分析1、 资产负债情况分析表
                                                                                       单位:元
                                                                                         本期期末
                                                                          上期期末
                                        本期期末数                                       金额较上
                                                                          数占总资
    项目名称             本期期末数     占总资产的       上期期末数                      期期末变
                                                                          产的比例
                                        比例(%)                                          动比例
                                                                            (%)
                                                                                           (%)
    交易性金融资产           3,285,254.80           0.18        666,894.40          0.04        392.62
    预付款项                20,519,889.70           1.11     39,322,327.18          2.32        -47.82
    其他应收款              52,930,605.20           2.85     19,628,689.44          1.16        169.66
    在建工程                                                  3,119,108.66          0.18       -100.00
    长期待摊费用             6,381,587.14           0.34      4,637,163.48          0.27         37.62
    应交税费                15,880,665.19           0.86        505,820.69          0.03      3,039.58交易性金融资产:本期持有短期国债逆回购预付款项:本期结算预付货款其他应收款:新增 3000 万元验资款在建工程:本期口服液及食品级车间改造项目转入固定资产长期待摊费用:本期支付工厂场地租赁费应交税费:本年应纳所得税额增加2、 公允价值计量资产、主要资产计量属性变化相关情况说明
                                                                                          单位:元
                                                                                对当期净利润的影
    项目名称                 期初余额         期末余额            当期变动
                                                                                响金额
    交易性金融资产           666,894.40       3,285,254.80        2,618,360.40      13,750.80
                                             2012 年年度报告摘要
    可供出售金融资产           615,834,400.00     675,618,200.00      59,783,800.00     87,389,470.58
    合计                       616,501,294.40     678,903,454.80      62,402,160.40     87,403,221.38(四) 核心竞争力分析报告期内公司主要板块均保持稳定发展局面,无重大因设备或技术升级换代、特许经营权丧失等导致公司核心竞争力受到严重影响的事项发生。(五) 投资状况分析1、 对外股权投资总体分析(1) 证券投资情况
         证                                                        期末账面价      占期末 报告期损
                                                    持有数量
    序     券    证券代     证券简    最初投资金                         值          证券总     益
    号     品      码         称      额(元)                                       投资比
                                                     (股)
         种                                                          (元)        例(%) (元)
         股               中国石
    1            601857                233,800.00          14,000     126,700.00       3.86     -9,800.00
         票               油
         股               东方明
    2            600832                855,084.80       100,480       558,528.80      17.00     28,134.40
         票               珠
                          1 天国
         债               债逆回
    3            204001               2,600,026.00    2,600,000      2,600,026.00     79.14
         券               购
                          -GC001
    报告期已出售证券投资损
                                         /                /             /            /       207,407.02
    益
                   合计             3,688,910.80          /        3,285,254.80      100     225,741.42(2) 持有其他上市公司股权情况
                                                                                               单位:元
                                                                                                      会
              证                    占该公                                                            计   股
    证券代        券     最初投资成     司股权                                           报告期所有       核   份
                                               期末账面价值         报告期损益
    码          简         本         比例                                             者权益变动       算   来
              称                    (%)                                                            科   源
                                                                                                      目
                                                                                                      可
                                                                                                      供
              交                                                                                      出
                                                                                                           法
              通                                                                                      售
    601328               4,950,000.00   0.0041     12,498,200.00          253,000.00         989,230.00        人
              银                                                                                      金
                                                                                                           股
              行                                                                                      融
                                                                                                      资
                                                                                                      产
                                          2012 年年度报告摘要
                                                                                                 可
                                                                                                 供
           兴                                                                                    出
                                                                                                      法
           业                                                                                    售
    601377          62,307,692.31    2.4545    663,120,000.00       101,690,553.62   60,579,500.00        人
           证                                                                                    金
                                                                                                      股
           券                                                                                    融
                                                                                                 资
                                                                                                 产
    合计         67,257,692.31      /       675,618,200.00       101,943,553.62   61,568,730.00   /    /(3) 持有非上市金融企业股权情况
                                                                                                会
                                                占该
                                                                                       报告期 计      股
                                  持有数量      公司                         报告期
    所持对象名     最初投资金额                              期末账面价值                 所有者 核      份
                                                股权                         损益
    称           (元)                                    (元)                     权益变 算      来
                                   (股)       比例                         (元)
                                                                                       动(元) 科    源
                                                (%)
                                                                                                目
                                                                                                 长
                                                                                                 期国泰君安证
                                                                                                 股
    券股份有限     285,408,969.68   21,918,296     0.3593    285,408,969.68
                                                                                                 权公司
                                                                                                 投
                                                                                                 资
                                                                                                 长
                                                                                                 期国泰君安投
                                                                                                 股
    资管理股份       1,857,938.87    1,752,148       0.127     1,857,938.87
                                                                                                 权有限公司
                                                                                                 投
                                                                                                 资
    合计        287,266,908.55                        /   287,266,908.55                         /    /2、 非金融类公司委托理财及衍生品投资的情况(1) 委托理财情况
    本年度公司无委托理财事项。(2) 委托贷款情况
    本年度公司无委托贷款事项。3、 募集资金使用情况
    报告期内,公司无募集资金或前期募集资金使用到本期的情况。4、主要子公司、参股公司分析
                                 2012 年年度报告摘要
                                                                            单位:万元
    子公司全     业务    注册资      经营范                                 营业收
                                                 总资产      净资产                    净利润
       称     性质      本            围                                  入上海昂立
                                  代理广
    广告有限公    服务
                     1,800.00    告等            2,885.97   1,847.42    2,905.70      -186.98司上海昂立
                                  酒店管
    同科经济发    服务
                     17,725.40   理             17,661.92   12,888.48   361.97        -745.95展有限公司上海诺德
                                  天然植
    生物实业有    工业
                     15,600.00   物制品         17,558.79   13,681.49   5,311.93      -130.59限公司
    上海交大                         生物制
    昂立生物制                       品销售及
              商业                                                      18,145.4
    品销售有限           1,500.00    其领域内       14,943.11    3,609.47                 -3,969.62
                                                                           4
    公司                             八技服务上海交大
                                  保健品
    昂立保健品    商业
                     1,000.00    生产销售        1,302.70    1,105.06   1,007.59       22.97有限公司上海昂立
                                  投资、企
    实业有限公    咨询
                     5,000.00    业管理等        9,022.95    3,292.21      -          -793.53司
                                  生物制南京昂立
                                 品、保健
    保健食品有    商业
                      100.00     食品等的          171.84       52.46     0.40         -47.54限责任公司
                                 销售
    北京昂立                         销售食
    商贸有限责    商业               品、生物
                      425.00                       990.65     -811.29   1,992.93         87.69
    任公司                           制品
    杭州昂立                         销售昂
    贸易有限公    商业               立一号口
                      50.00                      1,260.44   -2,118.68   1,978.42       -121.70
    司                               服液无锡昂立
                                  保健品
    营销有限责    商业
                      80.00      销售            1,349.95     -846.84   2,438.89       -348.86任公司上海诺农
                                  进出口
    国际贸易有    贸易
                      100.00     贸易              167.17      166.94          1.54      15.39限公司上海施惠
              投资                投资、企特投资管理
             管理    3,000.00    业管理等       11,504.41    1,819.82     475.29        -55.11有限公司
                                    2012 年年度报告摘要5、非募集资金项目情况
                                                                     单位:元 币种:人民币
                                         项目    本年度投入金     累计实际投入金    项目收
    项目名称            项目金额
                                         进度        额                 额          益情况国泰君安证券股份
                        285,408,969.68             1,950,190.56    285,408,969.68有限公司上海联创永钦创业
                         20,000,000.00                              20,000,000.00投资企业
       合计             305,408,969.68     /       1,950,190.56    305,408,969.68     /3.2 董事会关于公司未来发展的讨论与分析(一) 行业竞争格局和发展趋势公司主要运营板块的行业发展呈现以下趋势:1、中国人口红利的逐步消失和环保要求的提高,产业升级的新方向主要依靠高端制造业与大消费大服务产业。2、行业集中度提高,一是更强调食品安全及品质安全;二是专业化分工,因为品质来自于专业和专注;三是创新,模式的创新,理念的创新,技术的创新,产品的创新等。作为公司主业的保健品产业经过近二十年的积淀,已形成以上海为大本营,着力发展长三角,积极拓展其他区域的营销网络。以主要城市群为核心的孵化已逐步形成。营销渠道覆盖Shopping Mall、卖场、超市、药房、便利店等。同时,"天然元"品牌创建的专柜商业模式,开创了国外营养补充剂品牌进入国内销售的先河,目前正在持续完善,从单纯卖产品到组合套餐一站式的健康解决方案,从各自为据的分散式销售到专柜终端数据库的建立,实现资源共享,确保了产业在传统模式中的竞争力。随着人们生活方式、消费方式的改变,以电商、电视购物、呼叫中心、目录营销为主体的无店铺营销技术的日益兴起和聚焦,对传统通路的而言既是挑战又是机遇,代表着未来的趋势。(二) 公司发展战略公司现有保健品、房地产、股权投资三大板块。其中,股权投资板块主要包括金融股权及其他股权投资。目前,保健品板块在面临行业发展诸多不利因素的市场环境下,处于调整中蓄势,蓄势中发展的态势,基本保持了收入和利润较为稳健的增长;房地产板块受制于国家宏观调控政策,处于消化存量、择机发展阶段;投资板块中,金融股权投资公司正适度调整资产结构,积极尝试从资本参与型投资到自主经营的转型,以达到集聚竞争优势、拓展品牌内涵、分散投资风险、增加主营收入的目的。(三) 经营计划2013 年是昂立公司发展中较为关键的一年。在经济转型的大背景下,公司将继续围绕"三足鼎立"的发展战略,巩固保健品板块的经营业绩,挖掘金融板块的投资机会,积极创造公司新的经济增长点,实现公司的可持续发展,以良好的经济效益,回报股东和员工。1.保健品板块2013 年,公司保健品板块要保持稳定增长。进一步完善制度建设和内控管理,规范各项管理流程。加快网购销售平台和外地虚拟通路平台的市场拓展。扩大产品的销售市场,严格控制各项费用。加强过程管理,保证产品质量。要根据市场需求和政策法规,开发新产品,做
                                2012 年年度报告摘要好技术储备,增强公司的竞争力。2.股权投资板块2013 年,公司金融投资板块要继续扩大对类金融领域的投资。要稳健经营小额贷款公司。抓住发展机遇,利用公司的资金优势,尝试新的投资项目,提高股权投资板块的贡献度。3.房地产板块2013 年,公司房产板块积蓄力量,择机发展。要密切关注国家调控的动向,精心研究市场变化,把握发展机遇,经营好已有项目。4.日常管理2013 年,公司要进一步加强内控建设,在公司和控股子公司范围内落实各项内控制度,规范企业管理,防范市场风险,树立企业形象,推动公司持续、稳定、健康发展。全面开展质量管理和食品安全工作,增强员工的质量、食品安全意识,通过追求质量,不断找出问题,找到持续改进的方向。要强化企业信息化建设,提升管理水平。要完善公司的激励机制,提高员工的归属感。要进一步加强企业的文化建设,营造良好的工作氛围,增强企业凝聚力。(四)可能面对的风险1、保健品板块首先,保健食品新政的出台,预示着行业"食品级"发展方向已经走到了尽头,产品老批件的升级和新批件的获取成为首要瓶颈。其次,食品安全已成为全社会的众矢之的,民众对于食品安全忧心忡忡,使保健品经营企业如履薄冰;最后,营销模式面临着专业团队制度建设、各模式间的价格体系碰撞、实体和虚拟的整体联动、新品推广模式的创新、区域发展很不平衡等困扰。因此,公司将从以下几点加以应对:首先,加强昂立现有产品的梳理和益生菌类、天然元类等新品的研发申报,同时提升昂立及天然元品牌的等级及信任度;其次,在原料采购、生产工艺、质量控制等基础上,更要关注行业新政、包装运输、终端陈列、售后服务、危机处理等系统风险;最后,通过完善复合型通路的模式来顺应目标人群的细分需求,通过实体通路的虚拟化和虚拟通路的实体化,解决传统通路和虚拟通路的利益分配问题,共享品牌和数据库。在系统性管理流程、内控体系的基础上,保障创新商业模式的有效复制和管理。同时,加强不同模式的团队培养。2、房地产板块2013 年仍是国家实施房地产宏观调控的政策年,为稳定房价,国家及地方接连不断地集中出台相关调控新政策,整体形势不容乐观。为此房产板块将稳健经营,积极寻找机会,盘活无效和低效的资产,调整资产结构,集中有限资源向优势项目倾斜。3、股权投资板块金融投资板块的资本参与型,较难形成自身的竞争优势。因此,股权投资板将调整金融股权投资结构,积极发展自营类金融业务。同时调整及清理无效或低效的其他投资项目,提高资产利用效率。3.3 董事会对会计师事务所“非标准审计报告”的说明(一)董事会、监事会对会计师事务所“非标准审计报告”的说明√ 不适用(二) 董事会对会计政策、会计估计或核算方法变更的原因和影响的分析说明√ 不适用
                                     2012 年年度报告摘要(三)董事会对重要前期差错更正的原因及影响的分析说明√ 不适用3.4 利润分配或资本公积金转增预案(一)现金分红政策的制定、执行或调整情况公司现金红利分配由董事会拟定预案,报股东大会审议通过。2012年5月30日,公司2011年年度股东大会审议通过了2011年度利润分配方案,以公司2011年12月31日总股本31,200万股为基数,每10股派发现金红利1.20元(含税),共计派发现金红利3744万元。2012年6月26日公司发布了《二○一一年度分红派息实施公告》,股权登记日为2012年6月29日,除息日为2012年7月2日,现金红利发放日为2012年7月6日。此方案已实施完毕。(二)报告期内盈利且母公司未分配利润为正,但未提出现金红利分配预案的,公司应当详细披露原因以及未分配利润的用途和使用计划√ 不适用(三)公司近三年(含报告期)的利润分配方案或预案、资本公积金转增股本方案或预案
                                                                    单位:元 币种:人民币
                                                           分红年度合
                     每 10 股
            每 10 股            每 10 股                   并报表中归      占合并报表中归属
    分红年               派息数               现金分红的
            送红股              转增数                     属于上市公      于上市公司股东的
    度                (元)(含              数额(含税)
            数(股)            (股)                     司股东的净      净利润的比率(%)
                       税)
                                                             利润
    2012 年                 1.50              46,800,000.00   83,152,251.91              56.28
    2011 年                 1.20              37,440,000.00   55,602,502.72              67.34
    2010 年                 0.70              21,840,000.00   58,004,741.66              37.653.5 积极履行社会责任的工作情况社会责任工作情况公司在员工责任、经济与服务责任、诚信责任和环保责任等方面积极履行社会责任。员工责任方面,以公正、包容、责任、诚信的价值取向为指导。诚信责任方面,公司遵守法律法规和社会公德、商业道德以及行业规则,无重大违法、违规的负面信息。
    四、   涉及财务报告的相关事项4.1 与上年度财务报告相比,对财务报表合并范围发生变化的,公司应当作出具体说明。1、与上期相比本期新增合并单位 2 家,原因为:本年新设立两家子(或孙)公司:南京昂立保健食品有限责任公司、上海昂立海之宝食品有限公司。2、本期减少合并单位 1 家,原因为:本年上海昂立汇丰医药有限公司进入法院清算程序。4.2 公司年度财务报告被会计师事务所出具了标准无保留意见的审计报告。4.3 与上年度财务报告相比,公司会计政策、会计估计和核算方法未发生变化。4.4 报告期内,公司未发生重大会计差错更正需追溯重述。
数据加载中...
prevnext
手机查看股票